Relationship between quantitative radiographic assessments of interstitial lung disease and physiological and clinical features of systemic sclerosis

Extent of disease on high-resolution computed tomography lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung disease

(2012) O. A. Moore et al.   RHEUMATOLOGY

Clinical course of lung physiology in patients with scleroderma and interstitial lung disease: Analysis of the Scleroderma Lung Study Placebo Group

(2011) Dinesh Khanna et al.   ARTHRITIS AND RHEUMATISM

Predicting treatment outcomes and responder subsets in scleroderma-related interstitial lung disease

(2011) Michael D. Roth et al.   ARTHRITIS AND RHEUMATISM

Quantitative texture-based assessment of one-year changes in fibrotic reticular patterns on HRCT in scleroderma lung disease treated with oral cyclophosphamide

(2011) Hyun J. Kim et al.   EUROPEAN RADIOLOGY

Treatment of Scleroderma-Interstitial Lung Disease With Cyclophosphamide Is Associated With Less Progressive Fibrosis on Serial Thoracic High-Resolution CT Scan Than Placebo

(2009) Jonathan Goldin et al.   CHEST

HRCT and scleroderma: semiquantitative evaluation of lung damage and functional abnormalities

(2009) M. Bellia et al.   Radiologia Medica

Classification of Parenchymal Abnormality in Scleroderma Lung Using a Novel Approach to Denoise Images Collected via a Multicenter Study

(2008) Hyun J. Kim et al.   ACADEMIC RADIOLOGY

Interstitial Lung Disease in Systemic Sclerosis

(2008) Nicole S. L. Goh et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

High-Resolution CT Scan Findings in Patients With Symptomatic Scleroderma-Related Interstitial Lung Disease

(2008) Jonathan G. Goldin et al.   CHEST